Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older

Clinical trial NCT06507553 · COMPLETED

Trial details

NCT number: NCT06507553
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Healthy Volunteers

Start date: 2024-08-12
Primary completion: 2025-03-04
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.